Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis

Hum Mol Genet. 2012 Jun 15;21(12):2646-50. doi: 10.1093/hmg/dds089. Epub 2012 Mar 2.

Abstract

Neuronal ceroid lipofuscinoses (NCLs) comprise a heterogeneous group of metabolic storage diseases that present with the accumulation of autofluorescent lipopigment, neurodegeneration and premature death. Nine genes have been thus far identified as the cause of different types of NCL, with ages at onset ranging from around birth to adult, although the underlying etiology of the disease still remains elusive. We present a family with typical NCL pathology in which we performed exome sequencing and identified a single homozygous mutation in ATP13A2 that fully segregates with disease within the family. Mutations in ATP13A2 are a known cause of Kufor-Rakeb syndrome (KRS), a rare parkinsonian phenotype with juvenile onset. These data show that NCL and KRS may share etiological features and implicate the lysosomal pathway in Parkinson's disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amino Acid Sequence
  • Base Sequence
  • DNA Mutational Analysis
  • Exome / genetics
  • Family Health
  • Female
  • Genetic Predisposition to Disease / genetics*
  • Homozygote
  • Humans
  • Male
  • Molecular Sequence Data
  • Mutation*
  • Neuronal Ceroid-Lipofuscinoses / genetics*
  • Neuronal Ceroid-Lipofuscinoses / pathology
  • Parkinsonian Disorders / genetics*
  • Pedigree
  • Proton-Translocating ATPases / genetics*
  • Sequence Homology, Amino Acid

Substances

  • ATP13A2 protein, human
  • Proton-Translocating ATPases

Supplementary concepts

  • Kufor-Rakeb syndrome